Home › NDC Lookup › RxCUI directory › RxCUI 1739887

Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopo... — RxCUI 1739887

Name: Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG /… (RxCUI 1739887)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1739887 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1739887

Official nameAtropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Phenohytro]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asPhenohytro (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine HBr 0.0065 MG) Oral Tablet; Phenohytro 0.0194 MG / 0.1037 MG / 16.2 MG / 0.0065 MG Oral Tablet

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)73 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenobarbital: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Phenobarbital is mainly used to control seizures — including generalized tonic-clonic seizures (sometimes called grand mal seizures) and partial seizures. It's also used as a sedat...
What is phenobarbital actually used for?
Please don't stop it on your own. Phenobarbital can cause physical dependence, and stopping it suddenly — especially after taking it for a while — can trigger serious withdrawal sy...
Can I just stop taking phenobarbital if I feel better?

📖 Read our full Phenobarbital guide →

🕸️ Concept Web — How Atropine sulfate 0.0194 MG / hyoscyamine sulfate... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Phenohytro] RxCUI 1739887 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 8

The active substance itself — no strength, form, or brand attached yet.
- Atropine 1223 IN
- Hyoscyamine 153970 IN
- Phenobarbital 8134 IN
- Scopolamine 9601 IN
- Atropine / hyoscyamine / phenobarbital / scopolamine 689606 MIN
- Atropine sulfate 153971 PIN
- Hyoscyamine sulfate 1225 PIN
- Scopolamine hydrobromide 9603 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Phenohytro 1739882 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet 374677 SCDF
- Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Tablet 2647221 SCDFP
- Atropine / hyoscyamine / phenobarbital / scopolamine Oral Product 1154679 SCDG
- Atropine / hyoscyamine / phenobarbital / scopolamine Pill 1154680 SCDG
- Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Product 2661270 SCDGP
- Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Pill 2659870 SCDGP
- Atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet [Phenohytro] 1739884 SBDF
- Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Tablet [Phenohytro] 2656783 SBDFP
- +5 more in this family
Clinical & branded drugs 6

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet 1046815 SCD
- Atropine sulfate 0.0194 MG 1046805 SCDC
- Hyoscyamine sulfate 0.1037 MG 1046806 SCDC
- Phenobarbital 16.2 MG 316479 SCDC
- Scopolamine hydrobromide 0.0065 MG 1046807 SCDC
- Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG [Phenohytro] 1739883 SBDC

Showing up to 8 concepts per family — 23 of 28 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet SCD · 1046815
Atropine sulfate 0.0194 MG SCDC · 1046805
Hyoscyamine sulfate 0.1037 MG SCDC · 1046806
Phenobarbital 16.2 MG SCDC · 316479
Scopolamine hydrobromide 0.0065 MG SCDC · 1046807
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet SCDF · 374677
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Tablet SCDFP · 2647221
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Product SCDG · 1154679
Atropine / hyoscyamine / phenobarbital / scopolamine Pill SCDG · 1154680
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Product SCDGP · 2661270

Brand-Name Concepts

Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG [Phenohytro] SBDC · 1739883
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet [Phenohytro] SBDF · 1739884
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Tablet [Phenohytro] SBDFP · 2656783
Phenohytro Oral Product SBDG · 1739885
Phenohytro Pill SBDG · 1739886
Phenohytro BN · 1739882

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 1739887 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
75826-0118-00	1000 TABLET in 1 BOTTLE, PLASTIC (75826-118-00)	Phenohytro	Winder Laboratories, LLC	2016-02-29
75826-0118-10	100 TABLET in 1 BOTTLE, PLASTIC (75826-118-10)	Phenohytro	Winder Laboratories, LLC	2016-02-29

Observed labelers: Winder Laboratories, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$1.2548

Range $1.2548–$1.2548 · middle 50% $1.2548–$1.2548 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.